Persistently low plasma thioredoxin is associated with meningococcal septic shock in children

Intensive Care Medicine

Volumn 33, Issue 2, 2007, Pages 364-367

  Callister, Matthew E ^a   Burke Gaffney, Anne ^a   Quinlan, Gregory J ^a   Betts, Helen ^b   Nadel, Simon ^b   Evans, Timothy W ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Meningococcal infection; Oxidation reduction; Sepsis syndrome; Systemic inflammatory response syndrome; Thioredoxin

Indexed keywords

INTERLEUKIN 1BETA; THIOREDOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; HUMAN; INTENSIVE CARE; MENINGOCOCCOSIS; MORTALITY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPTIC SHOCK; SURVIVAL; TEACHING HOSPITAL;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; INTERLEUKIN-1BETA; MENINGOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THIOREDOXIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846885431     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0460-7     Document Type: Article

References (14)

1. Welch SB, Nadel S (2003) Treatment of meningococcal infection. Arch Dis Child 88:608-614
2. Festa M, Mumby S, Nadel S, Gutteridge JM, Quinlan GJ (2002) Antioxidant protection against iron in children with meningococcal sepsis. Crit Care Med 30:1623-1629
3. Gromer S, Urig S, Becker K (2004) The thioredoxin system - from science to clinic. Med Res Rev 24:40-89
4. Burke-Gaffney A, Callister ME, Nakamura H (2005) Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci 26:398-404
5. Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110-1116
6. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8:603-611
7. Holmgren A, Luthman M (1978) Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry 17:4071-4077
8. Callister ME, Burke-Gaffney A, Quinlan GJ, Nicholson AG, Florio R, Nakamura H, Yodoi J, Evans TW (2006) Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax 61:521-527
9. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397-400
10. Hazelzet JA, van der Voort E, Lindemans J, ter Heerdt PG, Neijens HJ (1994) Relation between cytokines and routine laboratory data in children with septic shock and purpura. Intensive Care Med 20:371-374
11. Ejima K, Koji T, Nanri H, Kashimura M, Ikeda M (1999) Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide. Placenta 20:561-566
12. Wollman EE, d'Auriol L, Rimsky L, Shaw A, Jacquot JP, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F (1988) Cloning and expression of a cDNA for human thioredoxin. J Biol Chem 263:15506-15:512
13. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D (2006) High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta 367:156-161
14. Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M (1999) 4G/5G promoter polymorphism in the plasminogenactivator- inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354:556-560